摘要
目的 观察二甲双胍对骨肉瘤细胞增殖及蛋白激酶B（Akt）信号通路中Akt、叉头框转录因子O亚族1（FoxO1）蛋白磷酸化的影响,探讨二甲双胍抑制骨肉瘤细胞增殖的作用机制.方法 以骨肉瘤MG63细胞株为研究对象,采用含有10％胎牛血清的RPMI 1640培养液在体外培养至细胞融合达70％时,更换终质量浓度为50 mmol/L的不含血清的培养液继续培养,在加入实验剂量的二甲双胍后12、24、36、48、72 h分别采用细胞计数试剂盒（CCK-8）法检测细胞的增殖,收获24 h的细胞,提取总蛋白后采用Western blot检测Akt、磷酸化Akt （p-Akt）、FoxO1、磷酸化FoxO1（p-FoxOl）的表达.结果 二甲双胍可显著抑制MG63细胞增殖,呈明显的时间依赖性,用药48 h后,MG63细胞内Akt、FoxO1的磷酸化水平明显下降.二甲双胍组的p-Akt和对照组的p-Akt水平分别为0.62 ±0.04和1.33±0.16（P＜0.05）,二甲双胍组的p-FoxO1和对照组的p-FoxO1水平分别为0.82 ±0.02和1.71±0.05（P ＜0.05）.结论 二甲双胍可通过Akt/FoxOl信号通路的去磷酸化而抑制MG63细胞的增殖.
Objective To investigate the effect of metformin on proliferation of osteosarcoma MG63 cells and protein kinase B （Akt） and forkhead box transcription factor O1 （FoxO1） phosphorylation in Akt signal pathway,and to explore the possible mechanism of metformin inhibiting proliferation of MG63 cells.Methods Osteosarcoma MG63 cells were cultured with RPMI 1640 supplemented with 10% fatal bovine serun （FBS） untill the cells reached 70% confluence,and cultured continuously with 50 mmol/L FBS-free RPMI 1640.Cell counting kit-8 （CCK-8） was used to test the proliferation of osteosarcoma cells treated with metformin at 12,24,36,48,and 72 h.After extraction of total protein,the Akt,p-Akt,FoxO1,and p-FoxO1 expression was analyzed by using Western blotting in MG63 cells at 24 h.Results The proliferation of the MG63 cells could be significantly inhibited by metformin in a time-independent manner,and protein Akt and FoxO1 phosphorylation could also be inhibited after 48 h.The p-Akt expression in metformin and control groups was 0.62 ± 0.04 and 1.33 ± 0.16 respectively （P 〈 0.05）.The p-FoxOl expression in metformin and control groups was 0.82 ±0.02 and 1.71 ±0.05 respectively （P 〈 0.05）.Conclusion Metformin can inhibit proliferation of osteosarcoma cells in vitro,which is associated with the dephosphorylation of Akt/FoxO1 signal pathway.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2014年第2期383-384,共2页
Chinese Journal of Experimental Surgery
关键词
二甲双胍
骨肉瘤
增殖
蛋白激酶B
Metformin
Osteosarcoma
Proliferation
Protein kinase B
